Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Horm+Res 2009 ; 72 Suppl 2 (ä): 57-63 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Genetic and pathogenetic aspects of Noonan syndrome and related disorders #MMPMID20029240
Zenker M
Horm Res 2009[Dec]; 72 Suppl 2 (ä): 57-63 PMID20029240show ga
Noonan syndrome (NS) and the clinically overlapping disorders cardio-facio-cutaneous syndrome, LEOPARD syndrome, Costello syndrome and Neurofibromatosis-Noonan syndrome share the clinical features of short stature, the same spectrum of congenital heart defects, and a similar pattern of craniofacial anomalies. It is now known that all these disorders are caused by mutations in components of the RAS-MAPK signaling pathway. This pathway was previously known for its involvement in tumorigenesis. This article reviews the current knowledge on underlying genetic alterations and possible pathogenetic mechanisms responsible for NS and related disorders. It discusses the relationship between a group of developmental disorders and oncogenes. Potential future treatment prospects are based on the possibility of inhibiting RAS-MAPK signaling by pharmaceuticals.
|Body Height[MESH]
|Costello Syndrome/genetics/physiopathology[MESH]
|Female[MESH]
|Growth Disorders/genetics[MESH]
|Heart Defects, Congenital/genetics[MESH]
|Humans[MESH]
|LEOPARD Syndrome/genetics/physiopathology[MESH]
|Male[MESH]
|Mitogen-Activated Protein Kinases/genetics[MESH]
|Mutation[MESH]
|Neurofibromatoses/genetics/physiopathology[MESH]
|Noonan Syndrome/*genetics/*physiopathology[MESH]
|Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics[MESH]